APhA President Michael D. Hogue talks with distinguished vaccine expert John Grabenstein about the two leading COVID-19 vaccine candidates. They discuss characteristics of each vaccine and the implications for delivery and dispensing.
Excerpted from the Nov. 5 episode of APhA’s weekly webinar on COVID-19. Listeners are invited to download a PDF copy of the webinar slides that are referenced in the episode.
APhA COVID-19 Resources: Know the Facts
Where's the Patient's Voice in Evidence-based Treatment & Research? | Pharmacist and Physician Opioid Collaborative